MedPath

Phase II study of narrow band ultraviolet therapy for treatment-refractory skin graft versus host disease complicated with allogeneic hematopoietic stem cell transplantatio

Phase 2
Recruiting
Conditions
skin GVHD
Registration Number
JPRN-UMIN000032426
Lead Sponsor
Kyoto Prefectural University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. Pregnant female patient 2. Poor control diabetes mellitus 3. Any severe infection 4. Treatment-difficult skin disease other than GVHD 5. Patients whom an attending physician consider not appropriate for study enrollment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall response rate
Secondary Outcome Measures
NameTimeMethod
1. Rates for complete response, partial response, stable disease, and progressive disease 2. Duration of response 3. Sparing effect on calcineurin inhibitor and corticosteroid 4. Adverse event(s) 5. Profile of immune cells
© Copyright 2025. All Rights Reserved by MedPath